James Fox's Net Worth
$4.34 Million
Who is James Fox?
James Fox has an estimated net worth of $4.34 Million. This is based on reported shares across multiple companies, which include Biota Pharmaceuticals, Inc., and GenMark Diagnostics, Inc..
SEC CIK
James Fox's CIK is 0001500591
Past Insider Trading and Trends
2013 was James Fox's most active year for acquiring shares with 3 total transactions. James Fox's most active month to acquire stocks was the month of April. 2021 was James Fox's most active year for disposing of shares, totalling 1 transactions. James Fox's most active month to dispose stocks was the month of March. 2014 saw James Fox paying a total of $21,375.00 for 16,277 shares, this is the most they've acquired in one year. In 2021 James Fox cashed out on 182,017 shares for a total of $4,377,508.85, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Biota Pharmaceuticals, Inc. (VXRT) Snapshot price: $0.88
InvestorJames Fox owns 8,700 units of Common Stock which is worth $7,656.00 and 2,500 units of Restricted Stock Unit which is worth $2,200.00. In the year 2012 James Fox acquired a total of 26,200 shares in Biota Pharmaceuticals, Inc. at a cost of $44,100.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.5K |
$2.49 | $6,225.00 | 2.5K |
Aug 11
| |||
Form 4/A
| +228.65% | 70K |
$2.03 | $142,100.00 | 100.61K |
Jun 10
| |||
Form 4
| +228.65% | 70K |
$1.99 | $139,300.00 | 100.61K |
Jun 9
| |||
Form 4
|
∞
| 7.5K |
$2.20 | $16,500.00 | 7.5K |
May 12
| |||
Form 4
|
∞
| 7.5K |
$2.85 | $21,375.00 | 7.5K |
May 15
| |||
Form 4/A
|
∞
| 8.7K |
—
|
—
| 8.7K |
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GenMark Diagnostics, Inc. No price found
InvestorJames Fox used to own units in Common Stock but no longer holds any shares there. In the year 2010 James Fox filed a total of 19 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -263.10K |
$24.05 | -$6,327,603.10 |
0
|
Apr 22
| |||
Form 4
| +4.21% | 7.36K |
—
|
—
| 182.02K |
Feb 18
| |||
Form 4
| +8.09% | 13.07K |
—
|
—
| 174.66K |
May 29
| |||
Form 4
| +12.49% | 9K |
$5.50 | $49,500.00 | 81.08K |
Mar 6
| |||
Form 4
| +19.08% | 25.89K |
—
|
—
| 161.6K |
May 31
| |||
Form 4
| +22.17% | 24.63K |
—
|
—
| 135.71K |
May 24
| |||
Form 4
| +10.09% | 10.18K |
—
|
—
| 111.08K |
May 25
| |||
Form 4
| +16.33% | 14.16K |
—
|
—
| 100.9K |
May 26
| |||
Form 4
| +19.97% | 12K |
$6.90 | $82,800.00 | 72.08K |
Oct 30
| |||
Form 4
| +14.23% | 10.81K |
—
|
—
| 86.74K |
May 28
| |||
Form 4
| +3.31% | 2.43K |
—
|
—
| 75.93K |
Aug 7
| |||
Form 4
| +9.45% | 6.34K |
—
|
—
| 73.5K |
May 29
| |||
Form 4
| +8.20% | 5.09K |
—
|
—
| 67.16K |
May 22
| |||
Form 4/A
| +65.64% | 23.81K |
$4.20 | $100,002.00 | 60.09K |
Jun 26
| |||
Form 4
|
∞
| 23.81K |
$4.20 | $100,002.00 | 23.81K |
Jun 26
| |||
Form 4
| +19.46% | 10.11K |
—
|
—
| 62.07K |
Jun 6
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 51.95K |
—
|
—
| 51.95K |
Sep 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |